title: Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment.
abstract: Tumor- or cancer-associated fibroblasts (CAFs) are one of the most abundant stromal cell types in different carcinomas and comprise a heterogeneous cell population. Classically, CAFs are assigned with pro-tumorigenic effects stimulating tumor growth and progression. More recent studies demonstrated also tumor-inhibitory effects of CAFs suggesting that tumor-residing fibroblasts exhibit a similar degree of plasticity as other stromal cell types. Reciprocal interactions with the tumor milieu and different sources of origin are emerging as two important factors underlying CAF heterogeneity. This review highlights recent advances in our understanding of CAF biology and proposes to expand the term of cellular "polarization," previously introduced to describe different activation states of various immune cells, onto CAFs to reflect their phenotypic diversity.
authors.affiliation: Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institutet , Stockholm , Sweden.
authors.forename: Martin
authors.initials: M
authors.lastname: Augsten
keywords: cancer; cancer-associated fibroblasts; polarization; tumor microenvironment; tumor promotion; tumor suppression
references.citation: J Cell Physiol. 2013 Aug;228(8):1651-7
references.pmid: 23460038
references.citation: Cancer Cell. 2004 Jul;6(1):17-32
references.pmid: 15261139
references.citation: PLoS One. 2009 Nov 23;4(11):e7965
references.pmid: 19956757
references.citation: Semin Cancer Biol. 2008 Oct;18(5):349-55
references.pmid: 18467122
references.citation: Cancer Res. 1999 Oct 1;59(19):5002-11
references.pmid: 10519415
references.citation: PLoS Biol. 2004 Feb;2(2):E7
references.pmid: 14737219
references.citation: Cell. 2009 Nov 25;139(5):891-906
references.pmid: 19931152
references.citation: Immunol Rev. 2008 Apr;222:145-54
references.pmid: 18363999
references.citation: Int J Cancer. 2011 Jun 15;128(12):2793-802
references.pmid: 20715102
references.citation: Cancer Res. 2012 Jun 1;72(11):2768-79
references.pmid: 22472119
references.citation: Mol Cells. 2013 Aug;36(2):138-44
references.pmid: 23839513
references.citation: Front Genet. 2013 Nov 27;4:261
references.pmid: 24348516
references.citation: Nat Med. 2013 Aug;19(8):1047-53
references.pmid: 23817022
references.citation: Cancer Res. 2007 Nov 1;67(21):10123-8
references.pmid: 17974953
references.citation: Oncogene. 2012 Mar 1;31(9):1130-42
references.pmid: 21804603
references.citation: Cell. 2008 May 16;133(4):704-15
references.pmid: 18485877
references.citation: Oncogene. 2014 May 8;33(19):2423-31
references.pmid: 23728338
references.citation: Am J Cancer Res. 2011;1(4):482-97
references.pmid: 21984967
references.citation: Cell. 2008 Jun 13;133(6):994-1005
references.pmid: 18555776
references.citation: Am J Pathol. 2011 Mar;178(3):1387-94
references.pmid: 21356388
references.citation: Cell Cycle. 2013 Jun 1;12(11):1791-801
references.pmid: 23656776
references.citation: J Clin Oncol. 2010 Sep 10;28(26):4022-8
references.pmid: 20644094
references.citation: Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12877-82
references.pmid: 12297622
references.citation: Cell. 2005 May 6;121(3):335-48
references.pmid: 15882617
references.citation: Cancer Res. 2004 Dec 1;64(23):8492-5
references.pmid: 15574751
references.citation: J Exp Med. 2013 Jun 3;210(6):1137-51
references.pmid: 23712428
references.citation: Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20212-7
references.pmid: 24277834
references.citation: Cancer Cell. 2010 Feb 17;17(2):135-47
references.pmid: 20138012
references.citation: J Vis Exp. 2013 Jan 14;(71):e4425
references.pmid: 23354290
references.citation: Biomed Res. 2009 Oct;30(5):315-8
references.pmid: 19887729
references.citation: PLoS One. 2012;7(2):e30563
references.pmid: 22363446
references.citation: J Cell Biochem. 2007 Jul 1;101(4):830-9
references.pmid: 17211838
references.citation: PLoS One. 2010 Mar 23;5(3):e9832
references.pmid: 20352126
references.citation: J Biol Chem. 2004 Mar 5;279(10):9115-24
references.pmid: 14645233
references.citation: Biochem Biophys Res Commun. 2013 Aug 2;437(3):397-402
references.pmid: 23831470
references.citation: Cancer Res. 2013 Feb 15;73(4):1287-97
references.pmid: 23243022
references.citation: Ups J Med Sci. 2012 May;117(2):187-95
references.pmid: 22509805
references.citation: Cancer Res. 2010 Sep 1;70(17):6945-56
references.pmid: 20699369
references.citation: J Immunol. 1986 Apr 1;136(7):2348-57
references.pmid: 2419430
references.citation: Cancer Res. 2008 Jun 1;68(11):4331-9
references.pmid: 18519693
references.citation: Nature. 2009 Oct 22;461(7267):1084-91
references.pmid: 19847259
references.citation: BMC Cancer. 2011 Jun 13;11:245
references.pmid: 21668992
references.citation: J Cell Biol. 2010 Oct 4;191(1):169-85
references.pmid: 20876278
references.citation: Nat Cell Biol. 2013 Jun;15(6):637-46
references.pmid: 23708000
references.citation: Nature. 2005 Dec 8;438(7069):820-7
references.pmid: 16341007
references.citation: Cell. 2011 Jun 10;145(6):926-40
references.pmid: 21663795
references.citation: Dev Cell. 2011 Aug 16;21(2):193-215
references.pmid: 21839917
references.citation: Cancer Res. 2013 Sep 1;73(17):5347-59
references.pmid: 23838935
references.citation: Science. 2004 Feb 6;303(5659):848-51
references.pmid: 14764882
references.citation: Biochem Biophys Res Commun. 2011 May 13;408(3):399-404
references.pmid: 21514273
references.citation: Cancer Res. 2013 Sep 15;73(18):5657-68
references.pmid: 23903958
references.citation: Cancer Cell. 2012 Nov 13;22(5):571-84
references.pmid: 23153532
references.citation: PLoS One. 2012;7(4):e35128
references.pmid: 22514714
references.citation: J Pathol. 2013 Jan;229(2):198-207
references.pmid: 22996812
references.citation: J Clin Invest. 2011 Feb;121(2):784-99
references.pmid: 21266779
references.citation: Cancer Res. 2013 May 15;73(10):3007-18
references.pmid: 23514705
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3414-9
references.pmid: 19218429
references.citation: Nature. 2008 Sep 18;455(7211):406-10
references.pmid: 18754008
references.citation: Cancer Res. 2012 Sep 15;72(18):4652-61
references.pmid: 22826604
references.citation: Science. 2010 Nov 5;330(6005):827-30
references.pmid: 21051638
references.citation: PLoS One. 2013 Jul 26;8(7):e68923
references.pmid: 23922669
references.citation: Cell. 2013 Aug 29;154(5):1060-1073
references.pmid: 23993096
references.citation: Nat Med. 2011 Mar;17(3):320-9
references.pmid: 21383745
references.citation: Cancer Cell. 2009 Sep 8;16(3):183-94
references.pmid: 19732719
references.citation: Nat Rev Cancer. 2008 Jan;8(1):56-61
references.pmid: 18059462
references.citation: Int J Oncol. 2013 Jun;42(6):1849-57
references.pmid: 23588876
references.citation: Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6991-6
references.pmid: 23559372
references.citation: Nature. 2006 Apr 27;440(7088):1222-6
references.pmid: 16642001
references.citation: Semin Cancer Biol. 2012 Aug;22(4):298-306
references.pmid: 22414911
references.citation: PLoS One. 2009;4(4):e4992
references.pmid: 19352430
references.citation: Antioxid Redox Signal. 2011 Jun 15;14(12):2361-71
references.pmid: 21235356
references.citation: BMC Med Genomics. 2012 Sep 06;5:39
references.pmid: 22954256
references.citation: Cancer Res. 2008 Oct 1;68(19):7819-27
references.pmid: 18829537
references.citation: Neoplasma. 2013;60(5):516-24
references.pmid: 23790170
references.citation: PLoS One. 2013 May 07;8(5):e63243
references.pmid: 23667593
references.citation: J Clin Invest. 2012 Mar;122(3):787-95
references.pmid: 22378047
references.citation: Biochem Biophys Res Commun. 2003 Sep 12;309(1):232-40
references.pmid: 12943687
references.citation: Nature. 2011 Dec 07;481(7379):85-9
references.pmid: 22158103
references.citation: Cancer Cell. 2011 Aug 16;20(2):229-45
references.pmid: 21840487
references.citation: Cancer Biol Ther. 2006 Dec;5(12):1640-6
references.pmid: 17106243
references.citation: EMBO J. 2012 Jun 13;31(12):2737-46
references.pmid: 22617421
references.citation: Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16002-7
references.pmid: 21911392
references.citation: Cancer Cell. 2011 Feb 15;19(2):257-72
references.pmid: 21316604
references.citation: Cancer Microenviron. 2012 Dec;5(3):187-93
references.pmid: 22627670
references.citation: Carcinogenesis. 2012 Jan;33(1):20-9
references.pmid: 22021907
references.citation: Cancer Res. 2009 Jan 1;69(1):369-78
references.pmid: 19118022
references.citation: Oncogene. 2010 Sep 16;29(37):5159-70
references.pmid: 20562917
references.citation: Nat Rev Cancer. 2012 Apr 19;12(5):323-34
references.pmid: 22513401
references.citation: Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1478-83
references.pmid: 23766387
references.citation: Trends Mol Med. 2013 Aug;19(8):447-53
references.pmid: 23769623
references.citation: Biochim Biophys Acta. 2013 Jul;1832(7):1070-8
references.pmid: 23123598
references.citation: Carcinogenesis. 2012 Aug;33(8):1553-62
references.pmid: 22610072
references.citation: PLoS One. 2013 Jun 28;8(6):e67533
references.pmid: 23840733